ym 264 has been researched along with ceruletide in 1 studies
| Studies (ym 264) | Trials (ym 264) | Recent Studies (post-2010) (ym 264) | Studies (ceruletide) | Trials (ceruletide) | Recent Studies (post-2010) (ceruletide) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 3,002 | 91 | 645 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, K; Umeda, M; Yamada, T; Yamano, M | 1 |
1 other study(ies) available for ym 264 and ceruletide
| Article | Year |
|---|---|
Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
Topics: Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney; Leukocyte Elastase; Lipase; Lipopolysaccharides; Liver; Lung; Male; Multiple Organ Failure; Organ Size; Pancreas; Pancreatitis; Piperazines; Platelet Membrane Glycoproteins; Pyridones; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfonamides; Survival Rate; Thiazoles; Thiazolidines; Time Factors | 1998 |